sovesudil

N/A

Report date: 2025/10/20 14:18:07
NME

Base Information

Drug Namesovesudil
Drug Alias NameAMA-0076PHP-201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated protein kinase 2 inhibitorsRho-associated protein kinase 1 inhibitors
TargetsRho-associated protein kinase 1Rho-associated protein kinase 2
Therapy Area/IndicationsGlaucomaOcular HypertensionEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmakem Nv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmakem Nv
Active IndicationsN/A
Inactive IndicationsGlaucomaOcular HypertensionEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A